Trial Profile
A Randomized, Double-Blind, Triple-Dummy, 3-Period Crossover Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Formulation of MOA-728 in Subjects on Stable Methadone Maintenance
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Methylnaltrexone bromide
- Indications Constipation
- Focus Pharmacodynamics
- Sponsors Bausch Health Companies; Salix Pharmaceuticals
- 29 Jul 2011 New trial record